US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Several distributor agreements in Europe for smart needle company Injeq

Free for publication 17.2.2022 at 13:00 EET The Finnish medical technology company Injeq Oy has entered into distribution agreements in Italy, Austria, France and Slovenia. In addition to the agreements now announced, Injeq has distributor agreements in Germany and the Nordic countries, including Finland. In total, the markets of nine countries cover about half of the European medical technology market as a whole. Injeq's distributor strategy is to partner with innovative medium-sized or smaller companies that know their customers personally and are experts in Injeq's product

Timo Hänninen appointed CEO of Injeq Oy

Injeq OyPress releaseFebruary 10, 2022 at 12:00 (EET) Timo Hänninen, Ph.D., MBA, has been appointed CEO of Injeq Oy. Hänninen will take up his position at 14.2.2022. Hänninen has previously served as the CEO of RUAG Space Finland Oy AB. Timo Hänninen is a professional with a long experience in managing technology organizations. He has extensive experience in international business development and strategy. During his career, Hänninen has worked in the fields of medical technology, cyber security and space technology, as well as in management positions at Nokia Corporation for

Smart needle company Injeq enters Nordic market

Injeq OyPress ReleaseFree for publication 3.2.2022 at 13:00 EET The Finnish smart needle company Injeq Oy has signed a distributor contract with the Swedish company Nords Medical. The agreement gives Injeq access to Finland, Sweden, Norway and Denmark, which covers almost 10 percent of the total EU market. The aim of the IQ-Tip® smart needle is to improve patient safety in lumbar punctures, where spinal fluid is sampled, or when drugs are administered into the spinal cavity. The smart needle tells you in real time when the tip of the needle reaches the cerebrospinal fluid,

Injeq’s IQ-Tip® needle receives CE certification – the Finnish innovation is ready for sales to the European market

Injeq Oy Press releaseJanuary 4, 2022 at 7:00 a.m. EET     The medical technology company Injeq’s development yielded the desired outcome after many years of efforts as the company’s IQ-Tip® needle received CE approval on December 21, 2021. The needle can be used in lumbar punctures from newborns to the elderly, treatment punctures of children with leukemia being one of the main indications. For medical devices, the CE certification translates to a marketing authorization in Europe. In other words, the company can expect a new era of growth as a result of the certification.

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media